Search

Your search keyword '"Jemos, C"' showing total 3 results
Start Over Author "Jemos, C" Publisher elsevier bv
3 results on '"Jemos, C"'

1. 95P Italian national policy to access molecular tumor boards: Opportunity or restraint for precision oncology?

Author

Crimini, E., primary, Bielo, L. Boscolo, additional, Marra, A., additional, Repetto, M., additional, Rocco, E. Guerini, additional, Ascione, L., additional, Zanzottera, C., additional, Ranghiero, A., additional, Belli, C., additional, Trapani, D., additional, Criscitiello, C., additional, Esposito, A., additional, Pravettoni, G., additional, Piperno, G., additional, Alterio, D., additional, Jemos, C., additional, Malengo, D., additional, Salè, E. Omodeo, additional, Barberis, M., additional, and Curigliano, G., additional

Published
2024
Full Text
View/download PDF

2. Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker

Author

Ursini, C.L., primary, Omodeo Salè, E., additional, Fresegna, A.M., additional, Ciervo, A., additional, Jemos, C., additional, Maiello, R., additional, Buresti, G., additional, Colosio, C., additional, Rubino, F.M., additional, Mandić-Rajčević, Stefan, additional, Chiarella, P., additional, Carbonari, D., additional, Delrio, P., additional, Maiolino, P., additional, Marchetti, P., additional, Boccia, R., additional, Iavicoli, S., additional, and Cavallo, D., additional

Published
2019
Full Text
View/download PDF

3. Benefits of e-cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months

Author

Ketti Mazzocco, C Jemos, Marianna Masiero, Gabriella Pravettoni, Claudio Lucchiari, Raffaella Bertolotti, Patrick Maisonneuve, Stefania Spina, Giulia Veronesi, Emanuela Omodeo Salè, Lucchiari, C., Masiero, M., Mazzocco, K., Veronesi, G., Maisonneuve, P., Jemos, C., Omodeo Sale, E., Spina, S., Bertolotti, R., and Pravettoni, G.

Subjects
Lung Diseases, Male, Nicotine, Nicotine-free e-cigarette, medicine.medical_specialty, Time Factors, Health Status, medicine.medical_treatment, Medicine (miscellaneous), Catarrh, Electronic Nicotine Delivery Systems, Smoking cessation, Toxicology, Placebo, law.invention, E-cigarette, Double-Blind Method, Randomized controlled trial, law, Internal medicine, medicine, Humans, Smoking Reduction, Early Detection of Cancer, Aged, Motivation, business.industry, Middle Aged, medicine.disease, Tobacco Use Cessation Devices, Clinical trial, Psychiatry and Mental health, Clinical Psychology, Pulmonary health, Female, Smoking Cessation, business, Lung cancer screening, medicine.drug
Abstract

Introduction: Electronic cigarettes (e-cigarettes) might be a valid and safe device to support smoking cessation. However, the available evidence is divergent. The aim of the present work was to assess the effects of an e-cigarette program on pulmonary health (cough, breath shortness, catarrh) and to evaluate the effectiveness of e-cigarettes in reducing tobacco consumption. Methods: The study is a double-blind randomized controlled trial. Two hundred and ten smokers were randomized into three groups: nicotine e-cigarette (8 mg/mL nicotine concentration), nicotine-free e-cigarettes (placebo), and control with 1:1:1 ratio. All participants received a 3 months cessation program that included a cognitive-behavioral intervention aimed at supporting people in changing their behavior and improving motivation to quit. Results: Pulmonary health, assessed with self-reported measures, clinical evaluations and the Leicester Cough Questionnaire, improved in participants who stopped smoking compared to their own baseline. No differences in pulmonary health were found between groups. Statistical tests showed a significant effect of Group (F (2, 118) = 4.005, p

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results